ClinicalTrials.gov record
A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment.
ClinicalTrials.gov ID: NCT01098539
Public ClinicalTrials.gov record NCT01098539. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Active-Controlled, Parallel-Group, Multicenter Study to Determine the Efficacy and Safety of Albiglutide as Compared With Sitagliptin in Subjects With Type 2 Diabetes Mellitus With Renal Impairment
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This randomized, double-blind, active-controlled study evaluates the efficacy and safety of a weekly dose of albiglutide as compared with sitagliptin. Subjects who are renally impaired with a historical diagnosis of type 2 diabetes mellitus and whose glycemia is inadequately controlled on their current regimen of diet and exercise or their antidiabetic therapy of metformin, thiazolidinedione, sulfonylurea, or any combination of these oral antidiabetic medications will be recruited into the study.
Study identification
- NCT ID
- NCT01098539
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 507 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 2010 (Type not available)
- Primary completion
- Nov 2012 (Actual)
- Completion
- Nov 2012 (Actual)
- Last update posted
- Feb 28, 2017
2010 – 2012
United States locations
- U.S. sites
- 121
- U.S. states
- 30
- U.S. cities
- 100
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| GSK Investigational Site | Birmingham | Alabama | 35294 | — |
| GSK Investigational Site | Gulf Shores | Alabama | 36542 | — |
| GSK Investigational Site | Huntsville | Alabama | 35801 | — |
| GSK Investigational Site | Toney | Alabama | 35773 | — |
| GSK Investigational Site | Phoenix | Arizona | 85028 | — |
| GSK Investigational Site | Fresno | California | 93720 | — |
| GSK Investigational Site | Huntington Beach | California | 92648 | — |
| GSK Investigational Site | Los Angeles | California | 90017 | — |
| GSK Investigational Site | Los Angeles | California | 90022 | — |
| GSK Investigational Site | Los Angeles | California | 90073 | — |
| GSK Investigational Site | Los Gatos | California | 95032 | — |
| GSK Investigational Site | Orange | California | 92868 | — |
| GSK Investigational Site | San Diego | California | 92120 | — |
| GSK Investigational Site | San Diego | California | 92161 | — |
| GSK Investigational Site | San Dimas | California | 91773 | — |
| GSK Investigational Site | Tarzana | California | 91356 | — |
| GSK Investigational Site | West Hills | California | 91307 | — |
| GSK Investigational Site | Whittier | California | 90602 | — |
| GSK Investigational Site | Whittier | California | 90603 | — |
| GSK Investigational Site | Doral | Florida | 33172 | — |
| GSK Investigational Site | Hollywood | Florida | 33021 | — |
| GSK Investigational Site | Jacksonville | Florida | 32205 | — |
| GSK Investigational Site | Miami | Florida | 33136 | — |
| GSK Investigational Site | Miami Beach | Florida | 33141 | — |
| GSK Investigational Site | New Port Richey | Florida | 34653 | — |
| GSK Investigational Site | Pembroke Pines | Florida | 33028 | — |
| GSK Investigational Site | Plantation | Florida | 33322 | — |
| GSK Investigational Site | Tampa | Florida | 33613 | — |
| GSK Investigational Site | Winter Park | Florida | 32789 | — |
| GSK Investigational Site | Winter Park | Florida | 32792 | — |
| GSK Investigational Site | Atlanta | Georgia | 30312 | — |
| GSK Investigational Site | Atlanta | Georgia | 30342 | — |
| GSK Investigational Site | Augusta | Georgia | 30909 | — |
| GSK Investigational Site | Blue Ridge | Georgia | 30513 | — |
| GSK Investigational Site | Decatur | Georgia | 30032 | — |
| GSK Investigational Site | Roswell | Georgia | 30076 | — |
| GSK Investigational Site | Stone Mountain | Georgia | 30088 | — |
| GSK Investigational Site | Valparaiso | Indiana | 46383 | — |
| GSK Investigational Site | Des Moines | Iowa | 50314 | — |
| GSK Investigational Site | Mission | Kansas | 66202 | — |
| GSK Investigational Site | Lexington | Kentucky | 40504 | — |
| GSK Investigational Site | Paducah | Kentucky | 42003 | — |
| GSK Investigational Site | Alexandria | Louisiana | 71301 | — |
| GSK Investigational Site | Bangor | Maine | 04401 | — |
| GSK Investigational Site | Hyattsville | Maryland | 20782 | — |
| GSK Investigational Site | Springfield | Massachusetts | 01107 | — |
| GSK Investigational Site | Dearborn | Michigan | 48124 | — |
| GSK Investigational Site | Detroit | Michigan | 48235 | — |
| GSK Investigational Site | Flint | Michigan | 48504 | — |
| GSK Investigational Site | Saint Clair Shores | Michigan | 48081 | — |
| GSK Investigational Site | Taylor | Michigan | 48180 | — |
| GSK Investigational Site | Kansas City | Missouri | 64111 | — |
| GSK Investigational Site | Kansas City | Missouri | 64128 | — |
| GSK Investigational Site | Springfield | Missouri | 65807 | — |
| GSK Investigational Site | Omaha | Nebraska | 68131 | — |
| GSK Investigational Site | Las Vegas | Nevada | 89102 | — |
| GSK Investigational Site | Las Vegas | Nevada | 89103 | — |
| GSK Investigational Site | North Massapequa | New York | 11758 | — |
| GSK Investigational Site | Staten Island | New York | 10301 | — |
| GSK Investigational Site | Asheville | North Carolina | 28801 | — |
| GSK Investigational Site | Hurst | North Carolina | 76054 | — |
| GSK Investigational Site | Shelby | North Carolina | 28150 | — |
| GSK Investigational Site | Tabor City | North Carolina | 28463 | — |
| GSK Investigational Site | Wilmington | North Carolina | 28401 | — |
| GSK Investigational Site | Winston-Salem | North Carolina | 27103 | — |
| GSK Investigational Site | Cincinnati | Ohio | 45219 | — |
| GSK Investigational Site | Cleveland | Ohio | 44195 | — |
| GSK Investigational Site | Gallipolis | Ohio | 45631 | — |
| GSK Investigational Site | Oklahoma City | Oklahoma | 73103 | — |
| GSK Investigational Site | Medford | Oregon | 97501 | — |
| GSK Investigational Site | Altoona | Pennsylvania | 16602 | — |
| GSK Investigational Site | Downington | Pennsylvania | 19335 | — |
| GSK Investigational Site | Philadelphia | Pennsylvania | 19146 | — |
| GSK Investigational Site | Charleston | South Carolina | 29412 | — |
| GSK Investigational Site | Columbia | South Carolina | 29204 | — |
| GSK Investigational Site | Greer | South Carolina | 29651 | — |
| GSK Investigational Site | North Myrtle Beach | South Carolina | 29582 | — |
| GSK Investigational Site | Taylors | South Carolina | 29687 | — |
| GSK Investigational Site | Bristol | Tennessee | 37620 | — |
| GSK Investigational Site | Franklin | Tennessee | 37067 | — |
| GSK Investigational Site | Knoxville | Tennessee | 37923 | — |
| GSK Investigational Site | Tullahoma | Tennessee | 37398 | — |
| GSK Investigational Site | Arlington | Texas | 76011 | — |
| GSK Investigational Site | Arlington | Texas | 76014 | — |
| GSK Investigational Site | Austin | Texas | 78751 | — |
| GSK Investigational Site | Austin | Texas | 78758 | — |
| GSK Investigational Site | Dallas | Texas | 75224 | — |
| GSK Investigational Site | Dallas | Texas | 75231 | — |
| GSK Investigational Site | Dallas | Texas | 75251 | — |
| GSK Investigational Site | Deer Park | Texas | 77536 | — |
| GSK Investigational Site | Fort Worth | Texas | 76104 | — |
| GSK Investigational Site | Grapevine | Texas | 76051 | — |
| GSK Investigational Site | Houston | Texas | 77027 | — |
| GSK Investigational Site | Houston | Texas | 77030 | — |
| GSK Investigational Site | Houston | Texas | 77036 | — |
| GSK Investigational Site | Houston | Texas | 77070 | — |
| GSK Investigational Site | Houston | Texas | 77074 | — |
| GSK Investigational Site | Houston | Texas | 77081 | — |
| GSK Investigational Site | Houston | Texas | 77088 | — |
| GSK Investigational Site | Houston | Texas | 77099 | — |
| GSK Investigational Site | Humble | Texas | 77338 | — |
| GSK Investigational Site | Hurst | Texas | 76054 | — |
| GSK Investigational Site | Irving | Texas | 75039 | — |
| GSK Investigational Site | Midland | Texas | 79707 | — |
| GSK Investigational Site | North Richland Hills | Texas | 76180 | — |
| GSK Investigational Site | Pearland | Texas | 77584 | — |
| GSK Investigational Site | Plano | Texas | 75075 | — |
| GSK Investigational Site | Richardson | Texas | 75080 | — |
| GSK Investigational Site | San Antonio | Texas | 78215 | — |
| GSK Investigational Site | San Antonio | Texas | 78217 | — |
| GSK Investigational Site | San Antonio | Texas | 78258 | — |
| GSK Investigational Site | Schertz | Texas | 78154 | — |
| GSK Investigational Site | Sugarland | Texas | 77479 | — |
| GSK Investigational Site | Tomball | Texas | 77375 | — |
| GSK Investigational Site | Bountiful | Utah | 84010 | — |
| GSK Investigational Site | South Burlington | Vermont | 05403 | — |
| GSK Investigational Site | Burke | Virginia | 22015 | — |
| GSK Investigational Site | Manassas | Virginia | 20110 | — |
| GSK Investigational Site | Norfolk | Virginia | 23510 | — |
| GSK Investigational Site | Salem | Virginia | 24153 | — |
| GSK Investigational Site | Tacoma | Washington | 98405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 97 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01098539, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 28, 2017 · Synced Oct 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01098539 live on ClinicalTrials.gov.